• Veea converted $4.13 million of NLabs Demand Notes into 41,329 shares of Series A-1 preferred stock on June 25, 2026.
• NLabs also received common stock warrants for 13,331,969 shares at a $0.31 exercise price, exercisable from Jan. 1, 2027 to June 25, 2031.
• Each Series A-1 share converts into 323 common shares, implying up to 13,331,969 shares on conversion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veea Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-072610), on June 26, 2026, and is solely responsible for the information contained therein.